Close Menu

UK government

The firm will use funds from the round, led by the Midlands Engine Investment Fund, to develop its optical point-of-care diagnostic testing platform.

Illumina officials discussed several issues with investors, including the new Qiagen partnership, while at ASHG the firm introduced reagent kit upgrades.

The UK Competition and Markets Authority said blocking the deal could prevent a "substantial lessening of competition" in the NGS market.

Nobel laureates bemoan the potential effects of a no-deal Brexit on science in the UK, the Guardian reports.

The project is funded with £50 million from the UK government, £50 million from the Wellcome Trust, and £100 million from four pharmaceutical firms.

UK Prime Minister Boris Johnson has announced a plan for "fast-track visas" to attract scientific talent to the UK post-Brexit, the Financial Times reports.

New UK Prime Minister Boris Johnson has selected his brother Jo Johnson, who is largely liked by researchers, to join the cabinet, Nature News reports.

Nature News examines how science in the UK may fare as Boris Johnson, the next prime minister, pursues Brexit.

The UK Competition and Markets Authority has announced concerns that the $1.2 billion merger will reduce competition for Illumina and could scrutinize it further.

On the Horizon

Paul Nurse, the director of the Francis Crick Institute, says British science will suffer if the UK isn't part of Horizon Europe funding scheme, according to the Guardian.

Pages

Forensic genetic firm Verogen has bought the genetic genealogy site GEDmatch.

Researchers have 3D-printed plastic bunnies that encase the information needed to make more such bunnies in DNA, according to Discover magazine.

Dan Rather, the former CBS Evening News anchor and executive producer of a new documentary, writes at the Guardian that everyone needs to know about CRISPR.

In PNAS this week: analysis of FOXA1 upregulation in ER-positive breast cancer, gene editing to correct recessive dystrophic epidermolysis bullosa, and more.